What were the key takeaways from Rithm Capital's earnings call?

Did Rithm Capital beat or miss consensus estimates last quarter?

What guidance did Rithm Capital's management provide for the next earnings period?

What is Rithm Capital's latest dividend and current dividend yield?

What does Rithm Capital do and what are its main business segments?

What is the market's earnings forecast for Rithm Capital next quarter?

What is the revenue and EPS growth rate for Rithm Capital year over year?

What is Rithm Capital's gross profit margin?

- **Acquisition-Driven Growth**: $18B AUM Crestline and $7B Paramount acquisitions expand product suite for LPs.
- **Mortgage Dominance**: Newrez delivers 20% ROE with $295M Q3 profit, 32% originations growth.
- **Valuation Catalysts**: Potential 15% Newrez listing and 18% ROE justify $17-18/share revaluation.
- **Capital Allocation**: No dividend hikes; redeploying $1.3B+ cash at 15-20% returns.
- **Risk Management**: Underwriting-first approach avoids ABF fraud risks seen in peers.

**【CEO Summary Section】**
- **Record Quarter Performance**: All business lines (Newrez, Genesis, investment portfolio) delivered strong results, generating $300M in earnings and 18% ROE. Cash and liquidity stood at $2.2B.
- **Strategic Acquisitions**: 
  - **Crestline Capital Management**: $18B AUM, expanding into credit, NAV lending, and insurance/reinsurance. Deal expected to close in December.
  - **Paramount REIT**: $7B office portfolio in NYC and SF, acquired at $600/ft vs. $2,500-3,000/ft replacement cost. 90% leased in NYC, 70% in SF, with potential for NOI growth.
- **Asset Management Growth**: 
  - Genesis Capital originations up 60% YoY to $1.2B, EBITDA expected to reach $120M in 2025.
  - Sculptor Capital raised $4.6B YTD, targeting $5B+ in 2026.
- **Valuation Thesis**: Public company trading at 0.8-0.9x book vs. 1.5-3x peers. Mortgage company alone could justify $17-18/share if spun off.

**【CFO Financial Commentary】**
- **Q3 Financials**: 
  - GAAP net income: $193.7M ($0.35/share)
  - Earnings available for distribution: $297M ($0.54/share)
  - ROE: 11% (GAAP), 18% (non-GAAP)
- **Liquidity Post-Acquisitions**: 
  - $1.3B cash post-Crestline/Paramount closings
  - $1B available via financing facilities
  - No equity raises planned for acquisitions
- **Balance Sheet Strength**: $47B total assets, $8.5B permanent capital

**【Mortgage Company Update】**
- **Newrez Performance**: 
  - Q3 pretax income (excl. MTM): $295M (20% YoY growth)
  - ROE: 20%
  - Direct originations up 32% YoY
  - Non-agency production up 120% YoY
- **Margin Management**: 
  - Weighted average margin: 114bps (down due to gov't streamline refinances)
  - Servicing income: $260M (11% YoY growth)
- **Technology Edge**: 
  - ReziAI platform costs $140/loan
  - 100,000+ monthly loan applications
  - New tools like ReziAssist automate 60% of loan officer calls

**【Q&A Highlights】**
- **Strategic Priorities**: 
  - Focus on asset management growth (ABF funds, direct lending)
  - Potential partial listing of Newrez (15% stake) to test market
  - No dividend increases; redeploying capital at 15-20% ROE
- **Paramount Capital Raise**: 
  - $300-500M from Rithm, $950M+ from third parties
  - Conversations with 5-10 LPs/day
- **Underwriting Risk**: 
  - ABF funds focus on underwriting first (non-QM, RTL)
  - Avoiding systemic risks seen in First Brands/Tricolor
- **RPT Strategy**: 
  - Explore direct lending opportunities
  - Tender offer if growth unachievable

RITM

RITM fundamentals

You can ask Aime